Sign Up for Our E-Newsletter

In The News

New Funding Awarded for Under 50 Research

Posted on April 22, 2015

2015 Blue Hope Research Award

Scientific research is crucial to better understand the causes and factors associated with colon cancer. That’s why we established the Blue Hope Research Award, a one-year fellowship providing vital resources and funding to a bright investigator interested in making his or her mark in the colon cancer space.

Last year, we used the American Association for Cancer Research’s (AACR) peer-review process to fund critical research on biomarkers. We’re excited to announce that last night we officially presented our second annual Blue Hope Research award to Kent W. Mouw, M.D., Ph.D from the Dana-Farber Cancer Institute at the AACR’s Annual Meeting in Philadelphia, PA. Read more

Backstreet’s Back…on the Big Screen!

Posted on January 30, 2015

Photo credit:

We took a trip down memory lane this week when we learned the legendary 90s pop band – the Backstreet Boys –  are meeting 2015 in the role of the comeback kids. Today, the best-selling boy band in history is launching a new documentary – Show ‘Em What You’re Made Of. The flick follows the evolution of the lives of these five very memorable men. It also marks BSB’s 22nd anniversary! (Is that frightening to anyone else?) Read more

In Next 15 Years, Incidence in 20-34 Year Olds to Increase 90%

Posted on January 12, 2015

Jason Spohn

Last month, the Journal of American Medical Association (JAMA Surgery) published a new article on the incidences of colon and rectal cancer, focusing on age groups and predictions for the future. We sat down with Patient Advocate Medical Consultant Dr. Laura Porter to get her take on the new study. Read more

Coming Down the Pipeline: TAS-102

Posted on November 6, 2014

1/26/2015 UPDATE: Great news for metastatic colon cancer patients refractory to or failing standard chemotherapy. Your team may be able to apply for expanded use for the sites that are currently offering the new drug TAS-102. More sites will be added soon. For teams that do not have access to the current sites, they can apply for compassionate use. Get more information about this update. Read more

Update: Cologuard Stool DNA Screening Test

Posted on October 31, 2014

Cologuard 1_small

This month, the Centers for Medicare & Medicaid Services (CMS) issued its final National Coverage Decision for Cologuard, making it the first FDA-approved stool DNA test for the detection of colon cancer and precancer covered for Medicare patients throughout the country. This came after the exciting US FDA approval of Cologuard in August. You may have heard some buzz earlier this week about Cologuard’s availability to the public. It turns out some of these facts were incorrect. In order to eliminate any confusion around this new colon cancer screening test, we’re setting the record straight. Check out our updated FAQ to find out what you need to know. Read more